Bulletin
Investor Alert

New York Markets After Hours

Mersana Therapeutics Inc.

NAS: MRSN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205377392/composite

$

21.28

Change

+0.42 +2.01%

Volume

Volume 7,685

Sep 22, 2020, 4:32 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205377392/composite

Today's close

$ 21.73

$ 20.86

Change

-0.87 -4.00%

Day low

Day high

$20.05

$21.59

Open
Open: 21.50

52 week low

52 week high

$1.32

$26.64

Open

Market cap

$1.49B

Average volume

950,976

P/E ratio

N/A

Rev. per Employee

$123,186

EPS

-1.37

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrsn

MarketWatch News on MRSN

  1. Biotechs Mersana Therapeutics, Crinetics See Activist Action

    9:30 p.m. April 24, 2020

    - Barron's Online

  2. Activist Legion Partners Wants NN to Change Its Name

    10:26 p.m. March 22, 2019

    - Barron's Online

  3. Mersana Therapeutics shares slump 6% in Monday premarket trading after J.P. Morgan downgrade

    8:17 a.m. March 11, 2019

    - Tonya Garcia

  4. Mersana Therapeutics downgraded to underweight from neutral at J.P. Morgan

    8:17 a.m. March 11, 2019

    - Tonya Garcia

  5. Mersana Therapeutics stock price target cut to $12 from $14 at Leerink

    10:20 a.m. Jan. 4, 2019

    - Tomi Kilgore

  6. Mersana to focus on advancing cancer treatment XMT-1356

    8:04 a.m. Jan. 4, 2019

    - Tomi Kilgore

  7. Mersana Therapeutics to discontinue development of cancer treatment XMT-1522

    8:04 a.m. Jan. 4, 2019

    - Tomi Kilgore

  8. CORRECTED: Salarius, Flex Pharma to merge to accelerate development of cancer treatments

    8:02 a.m. Jan. 4, 2019

    - Ciara Linnane

  9. Mersana Therapeutics, Flex Pharma halted premarket for news pending

    7:56 a.m. Jan. 4, 2019

    - Ciara Linnane

  10. Mersana Therapeutics shares up 4.7% premarket after resuming trade following halt

    7:33 a.m. Sept. 17, 2018

    - Ciara Linnane

  11. Mersana Therapeutics says FDA has lifted partial clinical hold on treatment for XMT-1522

    7:01 a.m. Sept. 17, 2018

    - Ciara Linnane

  12. Mersana shares halted for the news

    7:01 a.m. Sept. 17, 2018

    - Ciara Linnane

  13. Dow snaps 5-day win streak as financials sell off

    4:32 p.m. July 19, 2018

    - Ryan Vlastelica

  14. Mersana Therapeutics shares slide 51% as they resume trade after halt

    8:32 a.m. July 19, 2018

    - Ciara Linnane

  15. Mersana Therapeutics announces partial clinical hold for trial of cancer treatment

    8:02 a.m. July 19, 2018

    - Ciara Linnane

  16. Mersana Therapeutics shares halted for news

    7:56 a.m. July 19, 2018

    - Emma Court

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mrsn

Other News on MRSN

  1. MRSN, FSLR among premarket losers

    8:17 a.m. Sept. 17, 2020

    - Seeking Alpha

  2. Cancer advances ignite broad biotech and specialized ETF surge

    4:12 p.m. Sept. 15, 2020

    - Seeking Alpha

  3. VXRT, IMMU, GRPN and CODX among midday movers

    12:37 p.m. Sept. 14, 2020

    - Seeking Alpha

  4. NVDA, ORCL among premarket gainers

    8:39 a.m. Sept. 14, 2020

    - Seeking Alpha

  5. 10-Q: MERSANA THERAPEUTICS, INC.

    8:53 a.m. Aug. 7, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. Biotech Bonanza - Second Half Outlook

    8:24 a.m. July 28, 2020

    - Seeking Alpha

  7. Mersana's Shares March Higher, Can It Continue?

    7:50 a.m. June 26, 2020

    - Zacks.com

  8. 5 Top Stocks Up 100%+ in May With More Room to Run

    8:34 a.m. June 1, 2020

    - Zacks.com

  9. Loading more headlines...
/news/pressrelease/company/us/mrsn

Press Releases on MRSN

  1. Monday's ETF Movers: XBI, VTHR

    12:27 p.m. Sept. 14, 2020

    - MarketNewsVideo.com

  2. Monday Sector Leaders: Biotechnology, Drugs

    12:26 p.m. Sept. 14, 2020

    - MarketNewsVideo.com

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.